Chromophore-modified antitumor anthracenes. 1. Cytotoxic activity of 9-acyloxy 1,5-dichloroanthracene analogues

Chinese Pharmaceutical Journal

Volumn 53, Issue 2, 2001, Pages 71-83

  Huang, H S ^a   Hwang, J M ^a   Jen, Y M ^a   Tao, C W ^a   Lee, K Y ^a   Shi, C H ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Acylation; Anthracene; Anthracenone; Chromophore; Cytotoxicity

Indexed keywords

ACETIC ACID; ACYLATION; CELLS; HYDROCHLORIC ACID; REDUCTION; TUMORS;

CYTOTOXIC ACTIVITY;

CHROMOPHORES;

1,5 DICHLOROANTHRAQUINONE; 9 (4 CHLOROBUTYRYLOXY) 1,5 DICHLOROANTHRACENE; 9 ACYLOXY 1,5 DICHLOROANTHRACENE DERIVATIVE; 9 BENZOYLOXY 1,5 DICHLOROANTHRACENE; 9 DICHLOROACETOXY 1,5 DICHLOROANTHRACENE; 9 PHENYLACETYLOXY 1,5 DICHLOROANTHRACENE; ACETIC ACID; ANTHRACENE DERIVATIVE; ANTHRAQUINONE DERIVATIVE; ANTINEOPLASTIC AGENT; DOXORUBICIN; HYDROCHLORIC ACID; STANNIC CHLORIDE; UNCLASSIFIED DRUG;

ACYLATION; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CHINESE HAMSTER; CHROMATOPHORE; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; FEMALE; GROWTH INHIBITION; HEATING; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; OVARY CELL; REDUCTION; SQUAMOUS CELL CARCINOMA; STRUCTURE ACTIVITY RELATION; UTERINE CERVIX CARCINOMA;

EID: 0034851868     PISSN: 10161015     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Synthesis and antineoplastic evaluations of 5,8-bis[(aminoalkyl)amino]-1-azaanthracene-9,10-diones
2. Synthesis and antitumor activities of unsymmetrically substituted 1,4-bis[(aminoalkyl)-amino]anthracene-9,10-diones and related systems
3. DNA strand breakage by peroxidase-activated mitoxantrone
4. Anthracene-9,10-diones as potential anticancer agents: Bacterial mutation studies of amido-substituted derivatives reveal an unexpected lack of mutagenicity
5. Synthesis, DNA-binding and cytotoxic properties of a bis(netropsin)-anthracenedione conjugate
6. Similar sequence specificity of mitoxantrone and VM-26 stimulation of in vitro DNA cleavage by mammalian DNA topoisomerase II
7. Mitoxantrone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer
8. The geometry of intercalation complex of antitumor mitoxantrone and ametantrone with DNA: Molecular dynamics simulations
9. Mitoxantrone: Bluebeard for malignancies
10. Antipsoriatic anthrones with modulated redox properties. 3. 10-Thio-substituted 1,8-dihydroxy-9(10H)-anthracenones as inhibitors of keratinocyte growth, 5-lipoxygenase, and the formation of 12(S)-HETE in mouse epidermis
11. Treatment of psoriasis with anthrones-chemical principles, biochemical aspects, and approaches to the design of novel derivatives
12. Peptidyl anthraquinones as potential antineoplastic drugs: Synthesis, DNA binding, redox cycling, and biological activity
13. Chromophore-modified antitumor anthracenediones: Synthesis, DNA binding, and cytotoxic activity of 1,4-bis[(aminoalkyl)amino]benzo[g]-phthalazine- 5,10-diones
14. Synthesis, peroxidating ability, and antineoplastic evaluation of 1- [(aminoalkyl)-amino]-4-hydroxy-10-imino-9-anthracenones
15. Synthesis of unsymmetrical 1,4-bis[(aminoalkyl)amino]anthracene-9,10-diones for antineoplastic evaluation
16. Synthesis and antitumor evaluations of symmetrically and unsymmetrically substituted 1,4-bis[(aminoalkyl)amino]anthracene-9,10-diones and 1,4-bis[(aminoalkyl)amino]-5,8-dihydroxyanthracene-9,10-diones
17. 6,9-Bis[(aminoalkyl)amino]benzo[g]isoquinoline-5,10-diones. A novel class of chromophore-modified antitumor anthracene-9,10-diones: Synthesis and antitumor evaluations
18. Syntheses of anthracenones. 1. Sodium dithionite reduction of peri-substituted anthracenediones
19. Syntheses of anthracenones. 2. Preparation of 1,8-dimethoxy-(dimethylanthralin) and 4,5-dihydroxy-9(10H)-anthracenone (Isoanthralin): A revision
20. Syntheses of anthracenones. 3. Revised preparative route to 10-benzoyl-1,8-dihydroxy-9(10H)-anthracenones
21. A methodological approach to the prediction of anticancer drug effect in humans
22. Synthesis of 9-o-substituted derivatives of 9-hydroxy-5,6-dimethyl-6H- pyrido[4,3-b]carbazole-1-carboxylic acid (2-(dimethylamino)ethyl)amide and their 10- and 11-methyl analogues with improved antitumor activity
23. Antitumor activity of substituted 9-anilinoacridines comparison of in vivo and in vitro testing systems
24. Short-term cultures of clinical tumor material: Potential contributions to oncology research
25. The use of human cancer cell lines as a primary screening system for antineoplastic compounds